CorVel (NASDAQ:CRVL) VP Jennifer Yoss Sells 2,100 Shares of Stock

Key Points

• CorVel VP Jennifer Yoss sold 2,100 shares at an average price of $70.92, generating $148,932 and reducing her direct holdings by 49.15% to 2,173 shares. She also sold 1,999 shares in May for approximately $121,979.
• CorVel shares recently traded at $70.92, with a $3.62 billion market capitalization and a 52-week range of $44.83 to $93.45. The company reported quarterly EPS of $0.63 on revenue of $259.93 million.
• Analyst sentiment remains mixed but leans toward Hold: Weiss Ratings upgraded the stock to Hold, while Wall Street Zen upgraded it to Buy; institutional investors own 51.36% of outstanding shares.

CorVel Corp. (NASDAQ:CRVL - Get Free Report) VP Jennifer Yoss sold 2,100 shares of the stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $70.92, for a total transaction of $148,932.00. Following the transaction, the vice president directly owned 2,173 shares of the company's stock, valued at $154,109.16. The trade was a 49.15% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

Jennifer Yoss also recently made the following trade(s):

• On Tuesday, May 26th, Jennifer Yoss sold 1,999 shares of CorVel stock. The stock was sold at an average price of $61.02, for a total value of $121,978.98.

CorVel Stock Performance

Shares of NASDAQ CRVL traded up $0.78 during trading on Monday, reaching $70.92. The stock had a trading volume of 69,778 shares, compared to its average volume of 221,243. The company has a market cap of $3.62 billion, a P/E ratio of 31.54 and a beta of 0.98. CorVel Corp. has a fifty-two week low of $44.83 and a fifty-two week high of $93.45. The business's 50-day moving average price is $62.28 and its 200-day moving average price is $57.56.

CorVel (NASDAQ:CRVL - Get Free Report) last posted its earnings results on Tuesday, August 4th. The business services provider reported $0.63 earnings per share (EPS) for the quarter. The firm had revenue of $259.93 million for the quarter. CorVel had a return on equity of 29.92% and a net margin of 11.72%.

Analysts Set New Price Targets

A number of research firms recently weighed in on CRVL. Weiss Ratings upgraded shares of CorVel from a "sell (d+)" rating to a "hold (c-)" rating in a research note on Thursday, July 16th. Wall Street Zen upgraded shares of CorVel from a "hold" rating to a "buy" rating in a report on Saturday, May 30th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, CorVel has an average rating of "Hold".

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the business. Northwestern Mutual Wealth Management Co. acquired a new stake in shares of CorVel during the 3rd quarter worth about $31,000. Los Angeles Capital Management LLC purchased a new position in CorVel in the fourth quarter valued at approximately $33,000. Rockefeller Capital Management L.P. increased its stake in CorVel by 66.9% in the fourth quarter. Rockefeller Capital Management L.P. now owns 574 shares of the business services provider's stock valued at $39,000 after purchasing an additional 230 shares during the last quarter. Quarry LP raised its holdings in CorVel by 218.6% during the third quarter. Quarry LP now owns 513 shares of the business services provider's stock worth $40,000 after purchasing an additional 352 shares in the last quarter. Finally, Torren Management LLC acquired a new stake in CorVel during the fourth quarter worth approximately $46,000. 51.36% of the stock is owned by institutional investors and hedge funds.

CorVel Company Profile

CorVel Corporation NASDAQ: CRVL is a technology-driven provider of workers' compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel's integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support.

The company's product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source